Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?
Authors
Keywords
-
Journal
Viruses-Basel
Volume 14, Issue 3, Pages 534
Publisher
MDPI AG
Online
2022-03-07
DOI
10.3390/v14030534
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nitric oxide and COVID‐19: Dose, timing and how to administer it might be crucial
- (2021) Claes G. Frostell et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation
- (2021) Andrea Borghesi et al. Infectious Diseases
- Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities
- (2021) John P.A. Ioannidis et al. ENVIRONMENTAL RESEARCH
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Home NO Therapy for COVID-19
- (2020) Roger A. Alvarez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene
- (2020) Ettore D. Capoluongo et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
- (2020) Janet Sultana et al. DRUG SAFETY
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19
- (2020) Nagasai C. Adusumilli et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)
- (2020) Bijan Safaee Fakhr et al. OBSTETRICS AND GYNECOLOGY
- Azithromycin Differentially Alters TCR-Activated Helper T Cell Subset Phenotype and Effector Function
- (2020) Abdul Wahid Ansari et al. Frontiers in Immunology
- The Evolution of Covid-19 in Italy after the Spring of 2020: An Unpredicted Summer Respite Followed by a Second Wave
- (2020) Giuseppe De Natale et al. International Journal of Environmental Research and Public Health
- The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
- (2018) Petra Zimmermann et al. Frontiers in Immunology
- Inhaled nitric oxide
- (2018) Binglan Yu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential Modulation of Nitric Oxide Synthases in Aging: Therapeutic Opportunities
- (2012) Stefany B. A. Cau et al. Frontiers in Physiology
- Nitrative stress in inflammatory lung diseases
- (2011) Hisatoshi Sugiura et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Regulation of the expression of inducible nitric oxide synthase
- (2010) Andrea Pautz et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started